A Russian space official on Friday blamed a software problem on a newly docked science lab that briefly knocked the International Space Station out of position.
The space station lost control of its orientation for 47 minutes on Thursday, when Russia's Nauka science lab accidentally fired its thrusters a few hours after docking, pushing the orbiting complex from its normal configuration. The station’s position is key for getting power from solar panels and or communications. Communications with ground controllers also blipped out twice for a few minutes.
Vladimir Solovyov, flight director of the space station's Russian segment, blamed the incident on a “short-term software failure.” In a statement released by the Russian space agency Roscosmos on Friday, Solovyov said that because of the failure, a direct command to turn on the lab's engines was mistakenly implemented.
He added that the incident was “quickly countered by the propulsion system” of another Russian component at the station and “at the moment, the station is in its normal orientation” and all its systems “are operating normally.”
NASA said Thursday that the incident moved 45 degrees out of attitude, about one-eighth of a complete circle, but the complex was never spinning, there was no immediate damage or danger to the crew.
The incident caused NASA to postpone a repeat test flight for Boeing’s crew capsule that had been set for Friday afternoon from Florida. It will be Boeing’s second attempt to reach the 250-mile-high (400-kilomter-high) station before putting astronauts on board. Software problems botched the first test.
Russia’s long-delayed 22-ton (20-metric-ton) lab called Nauka arrived earlier Thursday, eight days after it launched from the Russian launch facility in Baikonur, Kazakhstan.
The launch of Nauka, which will provide more room for scientific experiments and space for the crew, had been repeatedly delayed because of technical problems. It was initially scheduled to go up in 2007.
In 2013, experts found contamination in its fuel system, resulting in a long and costly replacement. Other Nauka systems also underwent modernization or repairs.
Stretching 43 feet (13 meters) long, Nauka became the first new compartment for the Russian segment of the outpost since 2010. On Monday, one of the older Russian units, the Pirs spacewalking compartment, undocked from the station to free up room for the new lab.
Nauka will require many maneuvers, including up to 11 spacewalks beginning in early September, to prepare it for operation.
According to Solovyov, on Friday the crew was busy equalizing the pressure in Nauka and planned to open the hatch to the lab later in the day.
The space station is currently operated by NASA astronauts Mark Vande Hei, Shane Kimbrough and Megan McArthur; Oleg Novitsky and Pyotr Dubrov of Russia’s Roscosmos space corporation; Japan Aerospace Exploration Agency astronaut Akihiko Hoshide and European Space Agency astronaut Thomas Pesquet.
In 1998, Russia launched the station’s first compartment, Zarya, which was followed in 2000 by another big piece, Zvezda, and three smaller modules in the following years. The last of them, Rassvet, arrived at the station in 2010.
___
Seth Borenstein in Kensington, Maryland, and Vladimir Isachenkov in Moscow, contributed to this report.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
